Rubix LS
Delivering precision insight to create precision therapeutics with inclusive patient data
Connecting and powering the world's healthcare data through diversity patient analytics
Precision health research data points
Supported
Supported
Data Research & Analytics
Clinical Research
Consulting
Therapeutic Research
Federal Programs
Enable Patient Inclusivity. For
Better Health Outcomes
Precision Delivery
Using data and digital health to accelerate research to overcome disease and cancer health disparities
01
Characterize big data sets along with patient trends
02
Using precision intelligence, design and optimize clinical research to underserved communities using patient centric methodologies
03
Scale data for RWE and purpose data for therapeutic and healthcare innovation
Specialties
Uncovering the holistic picture to determine best paths of cancer and disease causes while developing targeted precision medicine strategies
Infectious Disease
Rare & Ultra Rare
Environmental
Oncology

Rubix CEO Outlines Vision for Greater Clinical Trial Patient Diversity
"We want to make sure that we put data into action to diversify the clinical trial patient population,” Reginald Swift, founder and CEO, Rubix LS told attendees of a panel at ATA2022 in Boston in early May 2022. “As we look to expand telehealth’s role in clinical trials, we...

It’s Time to Educate Minority Populations About the Benefits of Clinical Trials
By Reginald Swift, founder/CEO, Rubix LS Fresh off attending the ASCO 2022 conference, I was heartened to hear how much attention was focused on promoting minority participation in clinical trials. We all know it is the right thing to do morally, but it is also clear that diverse populations generate...

Rubix LS Applauds FDA Draft Guidance Calling for Enhanced Clinical Trial Diversity
“The moral, scientific, and business cases for promoting diversity in clinical trials have never been clearer,” says Reginald Swift, Ph. D, founder/CEO at Rubix Life Sciences. “It’s time to truly promote clinical trial diversity by harnessing data and working with experts who understand cultural nuances, especially for traditionally underserved patient...